Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 525 of 2228 entries
View as:

Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171741 Org: User:
Start: 04/30/05 End: - Due: -

Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01214109 Org: User:
Start: 12/31/10 End: - Due: -

Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL

Phase: N/A Priority: Normal
NCT ID: NCT02222974 Org: User:
Start: 01/31/99 End: - Due: -

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06041438 Org: User:
Start: 09/29/23 End: 11/10/23 Due: 11/10/24

A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT05985200 Org: User:
Start: 09/15/23 End: 08/19/24 Due: 08/19/25

Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02209779 Org: User:
Start: 05/31/01 End: - Due: -

Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls

Phase: N/A Priority: Normal
NCT ID: NCT01867307 Org: User:
Start: 06/30/13 End: 10/31/15 Due: 10/31/16

Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02256826 Org: User:
Start: 04/30/05 End: - Due: -

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT04614441 Org: User:
Start: 01/21/21 End: 05/14/25 Due: 05/14/26

Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)

Phase: N/A Priority: Normal
NCT ID: NCT02191241 Org: User:
Start: 08/31/01 End: - Due: -

Tiotropium and Salmeterol PK Study in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00673478 Org: User:
Start: 05/31/08 End: - Due: -

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT00239486 Org: User:
Start: 10/31/02 End: 04/30/04 Due: 04/30/05

A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00292448 Org: User:
Start: 02/28/06 End: 03/31/07 Due: 03/31/08

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03259490 Org: User:
Start: 08/31/17 End: 11/13/17 Due: 11/13/18

RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00621855 Org: User:
Start: 03/31/08 End: - Due: -

This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03414008 Org: User:
Start: 02/05/18 End: 11/18/19 Due: 11/18/20

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

Phase: N/A Priority: Normal
NCT ID: NCT03240575 Org: User:
Start: 08/14/17 End: 05/06/19 Due: 05/06/20

Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259933 Org: User:
Start: 02/29/04 End: - Due: -

Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02203864 Org: User:
Start: 08/31/98 End: - Due: -

12 / 48 Week Pivotal PFT vs PBO in COPD I

Phase: N/A Priority: Normal
NCT ID: NCT00782210 Org: User:
Start: 11/30/08 End: - Due: -

Japanese P III vs Voglibose and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00654381 Org: User:
Start: 04/30/08 End: - Due: -

Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182375 Org: User:
Start: 01/31/10 End: - Due: -

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02272413 Org: User:
Start: 07/08/15 End: 11/16/18 Due: 11/16/19

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02254707 Org: User:
Start: 07/31/04 End: - Due: -

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

Phase: N/A Priority: Normal
NCT ID: NCT00615563 Org: User:
Start: 03/31/07 End: 01/31/08 Due: 01/31/09